30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Endo International PLC (ENDP)

Track

Stock chart
Ticker: ENDP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MONTAGUE WILLIAM P
1 sale — total 78,406 USD
Sale 15 Mar 2021
Value US$2,889,081.90 | Price 469.16 | Shares 7,956
Sale 15 Mar 2021
Value US$3,265,658.75 | Price 469.35 | Shares 48,393
Planned sale 16 Sep 2019
Value US$122,700.00 | Price 4.09 | Shares 30,000
Planned sale 16 Sep 2019
Value US$102,250.00 | Price 4.09 | Shares 25,000
Planned sale 17 Jun 2019
Value US$39,300.00 | Price 3.93 | Shares 10,000
Planned sale 17 Jun 2019
Value US$98,057.43 | Price 3.93 | Shares 24,951
Sale 10 Dec 2018
Value US$114,100.00 | Price 11.41 | Shares 10,000
Planned sale 15 Nov 2018
Value US$128,300.00 | Price 12.83 | Shares 10,000
Planned sale 14 Aug 2018
Value US$222,600.00 | Price 15.90 | Shares 14,000
Planned sale 14 Aug 2018
Value US$191,976.60 | Price 15.90 | Shares 12,074
Planned sale 15 Nov 2017
Value US$27,600.00 | Price 6.90 | Shares 4,000
Planned sale 15 Nov 2017
Value US$35,424.60 | Price 6.90 | Shares 5,134
Buy 15 Aug 2017
Value US$24,060.00 | Price 8.02 | Shares 3,000
Buy 15 Aug 2017
Value US$51,285.00 | Price 7.89 | Shares 6,500
Buy 14 Aug 2017
Value US$50,115.00 | Price 7.71 | Shares 6,500
Buy 10 Aug 2017
Value US$154,000.00 | Price 7.70 | Shares 20,000
Buy 16 Mar 2017
Value US$24,656.00 | Price 10.72 | Shares 2,300
Planned sale 9 Mar 2017
Value US$57,616.50 | Price 10.82 | Shares 5,325
Planned sale 15 Nov 2016
Value US$910.50 | Price 18.21 | Shares 50
Planned sale 15 Nov 2016
Value US$120,721.50 | Price 17.37 | Shares 6,950
Planned sale 15 Nov 2016
Value US$910.50 | Price 18.21 | Shares 50
Planned sale 15 Nov 2016
Value US$120,721.50 | Price 17.37 | Shares 6,950
Buy 11 May 2016
Value US$69,000.00 | Price 13.80 | Shares 5,000
Buy 10 May 2016
Value US$77,400.00 | Price 15.48 | Shares 5,000
Buy 10 May 2016
Value US$31,320.00 | Price 15.66 | Shares 2,000
Buy 10 May 2016
Value US$169,620.00 | Price 15.42 | Shares 11,000
Buy 10 May 2016
Value US$201,890.00 | Price 15.53 | Shares 13,000
Buy 17 Mar 2016
Value US$29,200.00 | Price 29.20 | Shares 1,000
Buy 16 Mar 2016
Value US$35,240.00 | Price 35.24 | Shares 1,000
Buy 14 Mar 2016
Value US$47,182.50 | Price 41.94 | Shares 1,125
Buy 7 Mar 2016
Value US$22,240.00 | Price 44.48 | Shares 500
Buy 7 Mar 2016
Value US$100,125.00 | Price 44.50 | Shares 2,250
Sale 1 Mar 2016
Value US$143,994.47 | Price 42.19 | Shares 3,413
Sale 1 Mar 2016
Value US$143,994.47 | Price 42.19 | Shares 3,413
Sale 1 Mar 2016
Value US$143,994.47 | Price 42.19 | Shares 3,413
Sale 1 Mar 2016
Value US$143,994.47 | Price 42.19 | Shares 3,413
Buy 16 Nov 2015
Value US$47,937.00 | Price 57.00 | Shares 841
Buy 12 Nov 2015
Value US$228,520.00 | Price 57.13 | Shares 4,000
Buy 11 Nov 2015
Value US$195,546.00 | Price 56.68 | Shares 3,450
Buy 11 Nov 2015
Value US$55,310.00 | Price 55.31 | Shares 1,000
Buy 11 Nov 2015
Value US$11,276.00 | Price 56.38 | Shares 200
Buy 11 Nov 2015
Value US$105,678.00 | Price 55.62 | Shares 1,900
Sale 11 Nov 2015
Value US$443,840.00 | Price 55.48 | Shares 8,000
Buy 11 Nov 2015
Value US$55,350.00 | Price 55.35 | Shares 1,000
Buy 11 Nov 2015
Value US$39,529.00 | Price 56.47 | Shares 700
Buy 11 Nov 2015
Value US$28,095.00 | Price 56.19 | Shares 500
Buy 11 Nov 2015
Value US$500,013.12 | Price 55.52 | Shares 9,006
Buy 16 Jun 2015
Value US$202,750.00 | Price 81.10 | Shares 2,500
Planned sale 8 Apr 2015
Value US$9,654,922.10 | Price 91.90 | Shares 105,059
Planned sale 7 Apr 2015
Value US$46,225.70 | Price 91.90 | Shares 503
Sale 10 Mar 2015
Value US$773,223.50 | Price 89.39 | Shares 8,650
Sale 9 Mar 2015
Value US$3,518,914.76 | Price 87.02 | Shares 40,438
Sale 5 Mar 2015
Value US$3,689,656.74 | Price 87.78 | Shares 42,033
Sale 4 Mar 2015
Value US$495,030.00 | Price 85.35 | Shares 5,800
Buy 14 Nov 2014
Value US$247,678.00 | Price 66.94 | Shares 3,700
Buy 5 Aug 2014
Value US$229,775.00 | Price 65.65 | Shares 3,500
Planned sale 9 Jun 2014
Value US$465,566.12 | Price 68.83 | Shares 6,764
Planned sale 29 May 2014
Value US$12,605,876.66 | Price 72.02 | Shares 175,033
Planned sale 1 May 2014
Value US$536,713.14 | Price 66.31 | Shares 8,094
Planned sale 1 Apr 2014
Value US$710,888.64 | Price 68.46 | Shares 10,384
Sale 10 Mar 2014
Value US$478,809.29 | Price 72.47 | Shares 6,607
Sale 10 Mar 2014
Value US$1,603,471.22 | Price 72.47 | Shares 22,126
Sale 10 Mar 2014
Value US$2,258,310.14 | Price 72.47 | Shares 31,162
Sale 10 Mar 2014
Value US$1,140,822.74 | Price 72.47 | Shares 15,742
Sale 10 Mar 2014
Value US$360,600.00 | Price 72.12 | Shares 5,000
Buy 10 Mar 2014
Value US$365,000.00 | Price 73.00 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-16 2021-03-15 S Sale
3.3
MONTAGUE WILLIAM P
Non-Executive Director
7,956 +34.4%
469.16
US$2,889,082 		7,956 +34.4% 469.16 US$2,889,082
2021-03-15 2021-03-15 S Sale
3.3
Cooke Shane
Non-Executive Director
48,393 -19.8%
469.35
US$3,265,659 		48,393 -19.8% 469.35 US$3,265,659
2019-09-17 2019-09-16 PlS Planned sale
KIMMEL ROGER H
65,781 -44.8%
80.35
US$1,923,784 		65,781 -44.8% 80.35 US$1,923,784
2019-09-17 2019-09-16 PlS Planned sale
KIMMEL ROGER H
25,000 -16.9%
4.09
US$102,250 		25,000 -16.9% 4.09 US$102,250
2019-06-19 2019-06-17 PlS Planned sale
KIMMEL ROGER H
10,000 -8.3%
3.93
US$39,300 		10,000 -8.3% 3.93 US$39,300
2019-06-19 2019-06-17 PlS Planned sale
KIMMEL ROGER H
24,951 -14.4%
3.93
US$98,057 		24,951 -14.4% 3.93 US$98,057
2018-12-10 2018-12-10 S Sale MONTAGUE WILLIAM P Non-Executive Director
10,000 -13.4%
11.41
US$114,100 		10,000 -13.4% 11.41 US$114,100
2018-11-16 2018-11-15 PlS Planned sale Hutson Nancy J Non-Executive Director
10,000 -16.7%
12.83
US$128,300 		10,000 -16.7% 12.83 US$128,300
2018-08-15 2018-08-14 PlS Planned sale KIMMEL ROGER H Non-Executive Director
14,000 -10.4%
15.90
US$222,600 		14,000 -10.4% 15.90 US$222,600
2018-08-15 2018-08-14 PlS Planned sale KIMMEL ROGER H Non-Executive Director
12,074 -7.7%
15.90
US$191,977 		12,074 -7.7% 15.90 US$191,977
2017-11-17 2017-11-15 PlS Planned sale KIMMEL ROGER H
4,000 -2.9%
6.90
US$27,600 		4,000 -2.9% 6.90 US$27,600
2017-11-17 2017-11-15 PlS Planned sale KIMMEL ROGER H
5,134 -3.6%
6.90
US$35,425 		5,134 -3.6% 6.90 US$35,425
2017-08-15 2017-08-15 B Purchase Maletta Matthew Joseph

EVP, Chief Legal Officer
3,000 +75.3%
8.02
US$24,060 		3,000 +75.3% 8.02 US$24,060
2017-08-15 2017-08-15 B Purchase Coleman Blaise

EVP, Chief Financial Officer
6,500 +89.9%
7.89
US$51,285 		6,500 +89.9% 7.89 US$51,285
2017-08-15 2017-08-14 B Purchase Campanelli Paul

President, CEO

Executive Director
6,500 +3.1%
7.71
US$50,115 		6,500 +3.1% 7.71 US$50,115
2017-08-11 2017-08-10 B Purchase Coughlin Terrance J

EVP, Chief Operating Officer
20,000 +16.6%
7.70
US$154,000 		20,000 +16.6% 7.70 US$154,000
2017-03-16 2017-03-16 B Purchase Campanelli Paul

President, CEO

Executive Director
2,300 +1.1%
10.72
US$24,656 		2,300 +1.1% 10.72 US$24,656
2017-03-10 2017-03-09 PlS Planned sale Hutson Nancy J
5,325 -14.6%
10.82
US$57,616 		5,325 -14.6% 10.82 US$57,616
2016-11-16 2016-11-15 PlS Planned sale KIMMEL ROGER H Non-Executive Director
50 -0.0%
18.21
US$910 		50 -0.0% 18.21 US$910
2016-11-16 2016-11-15 PlS Planned sale KIMMEL ROGER H Non-Executive Director
6,950 -3.6%
17.37
US$120,722 		6,950 -3.6% 17.37 US$120,722
2016-11-16 2016-11-15 PlS Planned sale KIMMEL ROGER H Non-Executive Director
50 -0.1%
18.21
US$910 		50 -0.1% 18.21 US$910
2016-11-16 2016-11-15 PlS Planned sale KIMMEL ROGER H Non-Executive Director
6,950 -9.2%
17.37
US$120,722 		6,950 -9.2% 17.37 US$120,722
2016-05-12 2016-05-11 B Purchase HIGGINS ARTHUR J Non-Executive Director
5,000 +11.0%
13.80
US$69,000 		5,000 +11.0% 13.80 US$69,000
2016-05-11 2016-05-10 B Purchase KIMMEL ROGER H Non-Executive Director
5,000 +2.6%
15.48
US$77,400 		5,000 +2.6% 15.48 US$77,400
2016-05-11 2016-05-10 B Purchase KIMMEL ROGER H Non-Executive Director
2,000 +2.7%
15.66
US$31,320 		2,000 +2.7% 15.66 US$31,320
2016-05-11 2016-05-10 B Purchase HIGGINS ARTHUR J Non-Executive Director
11,000 +31.8%
15.42
US$169,620 		11,000 +31.8% 15.42 US$169,620
2016-05-11 2016-05-10 B Purchase Campanelli Paul

Group President, Generics

Officer
13,000 +6.9%
15.53
US$201,890 		13,000 +6.9% 15.53 US$201,890
2016-03-17 2016-03-17 B Purchase Spengler William Non-Executive Director
1,000 +2.1%
29.20
US$29,200 		1,000 +2.1% 29.20 US$29,200
2016-03-16 2016-03-16 B Purchase Spengler William Non-Executive Director
1,000 +2.1%
35.24
US$35,240 		1,000 +2.1% 35.24 US$35,240
2016-03-14 2016-03-14 B Purchase KIMMEL ROGER H Non-Executive Director
1,125 +1.6%
41.94
US$47,182 		1,125 +1.6% 41.94 US$47,182
2016-03-07 2016-03-07 B Purchase Maletta Matthew Joseph

Exec. V.P.,Chief Legal Officer

Officer
500 +100.0%
44.48
US$22,240 		500 +100.0% 44.48 US$22,240
2016-03-07 2016-03-07 B Purchase DE SILVA RAJIV

President & CEO

Executive Director
2,250 +0.9%
44.50
US$100,125 		2,250 +0.9% 44.50 US$100,125
2016-03-03 2016-03-01 S Sale Smith Jill D. Non-Executive Director
3,413 -14.7%
42.19
US$143,994 		3,413 -14.7% 42.19 US$143,994
2016-03-03 2016-03-01 S Sale Spengler William Non-Executive Director
3,413 -6.8%
42.19
US$143,994 		3,413 -6.8% 42.19 US$143,994
2016-03-03 2016-03-01 S Sale Hutson Nancy J Non-Executive Director
3,413 -8.5%
42.19
US$143,994 		3,413 -8.5% 42.19 US$143,994
2016-03-03 2016-03-01 S Sale HYATT MICHAEL Non-Executive Director
3,413 -1.3%
42.19
US$143,994 		3,413 -1.3% 42.19 US$143,994
2015-11-17 2015-11-16 B Purchase KIMMEL ROGER H Non-Executive Director
841 +0.8%
57.00
US$47,937 		841 +0.8% 57.00 US$47,937
2015-11-12 2015-11-12 B Purchase Cooke Shane Non-Executive Director
4,000 +64.7%
57.13
US$228,520 		4,000 +64.7% 57.13 US$228,520
2015-11-12 2015-11-11 B Purchase Upadhyay Suketu

EVP, Chief Financial Officer

Officer
3,450 +27.7%
56.68
US$195,546 		3,450 +27.7% 56.68 US$195,546
2015-11-12 2015-11-11 B Purchase Campanelli Paul

President, Par Pharmaceutical

Officer
200 +0.1%
56.38
US$11,276 		200 +0.1% 56.38 US$11,276
2015-11-12 2015-11-11 S Sale HYATT MICHAEL Non-Executive Director
8,000 -3.1%
55.48
US$443,840 		8,000 -3.1% 55.48 US$443,840
2015-11-12 2015-11-11 B Purchase Hall Susan

EVP, CSO, Global Head of R&D

Officer
1,000 +60.0%
55.35
US$55,350 		1,000 +60.0% 55.35 US$55,350
2015-11-12 2015-11-11 B Purchase Lortie Brian

President Branded Pharma

Officer
700 +4.2%
56.47
US$39,529 		700 +4.2% 56.47 US$39,529
2015-11-12 2015-11-11 B Purchase Upadhyay Suketu

EVP, Chief Financial Officer

Officer
1,000 +8.7%
55.31
US$55,310 		1,000 +8.7% 55.31 US$55,310
2015-11-12 2015-11-11 B Purchase Campanelli Paul

President, Par Pharmaceutical

Officer
1,900 +1.0%
55.62
US$105,678 		1,900 +1.0% 55.62 US$105,678
2015-11-12 2015-11-11 B Purchase Maletta Matthew Joseph

Exec. V.P.,Chief Legal Officer

Officer
500 +inf%
56.19
US$28,095 		500 +inf% 56.19 US$28,095
2015-11-12 2015-11-11 B Purchase DE SILVA RAJIV

President & CEO

Executive Director
9,006 +5.2%
55.52
US$500,013 		9,006 +5.2% 55.52 US$500,013
2015-06-18 2015-06-16 B Purchase HIGGINS ARTHUR J Non-Executive Director
2,500 +12.3%
81.10
US$202,750 		2,500 +12.3% 81.10 US$202,750
2015-04-09 2015-04-08 PlS Planned sale MANOGUE CAROLINE B

Exec. V.P.,Chief Legal Officer

Officer
105,059 -70.9%
91.90
US$9,654,922 		105,059 -70.9% 91.90 US$9,654,922
2015-04-09 2015-04-07 PlS Planned sale MANOGUE CAROLINE B

Exec. V.P.,Chief Legal Officer

Officer
503 -1.2%
91.90
US$46,226 		503 -1.2% 91.90 US$46,226
2015-03-12 2015-03-10 S Sale Farhat Camille

President, AMS, Inc.

Officer
8,650 -100.0%
89.39
US$773,224 		8,650 -100.0% 89.39 US$773,224
2015-03-11 2015-03-09 S Sale Farhat Camille

President, AMS, Inc.

Officer
40,438 -82.4%
87.02
US$3,518,915 		40,438 -82.4% 87.02 US$3,518,915
2015-03-09 2015-03-05 S Sale MANOGUE CAROLINE B

Exec. V.P.,Chief Legal Officer

Officer
42,033 -49.4%
87.78
US$3,689,657 		42,033 -49.4% 87.78 US$3,689,657
2015-03-06 2015-03-04 S Sale Lortie Brian

President Branded Pharma

Officer
5,800 -25.7%
85.35
US$495,030 		5,800 -25.7% 85.35 US$495,030
2014-11-18 2014-11-14 B Purchase Upadhyay Suketu

EVP, Chief Financial Officer

Officer
3,700 +105.1%
66.94
US$247,678 		3,700 +105.1% 66.94 US$247,678
2014-08-07 2014-08-05 B Purchase HIGGINS ARTHUR J Non-Executive Director
3,500 +65.7%
65.65
US$229,775 		3,500 +65.7% 65.65 US$229,775
2014-06-10 2014-06-09 PlS Planned sale DELUCCA JOHN Non-Executive Director
6,764 -19.4%
68.83
US$465,566 		6,764 -19.4% 68.83 US$465,566
2014-06-02 2014-05-29 PlS Planned sale MANOGUE CAROLINE B

Exec. V.P., CLO & Secy

Officer
175,033 -83.5%
72.02
US$12,605,877 		175,033 -83.5% 72.02 US$12,605,877
2014-05-02 2014-05-01 PlS Planned sale DELUCCA JOHN Non-Executive Director
8,094 -27.3%
66.31
US$536,713 		8,094 -27.3% 66.31 US$536,713
2014-04-02 2014-04-01 PlS Planned sale DELUCCA JOHN Non-Executive Director
10,384 -32.5%
68.46
US$710,889 		10,384 -32.5% 68.46 US$710,889
2014-03-11 2014-03-10 S Sale Gergel Ivan P.

EVP, R&D and CSO

Officer
6,607 -19.3%
72.47
US$478,809 		6,607 -19.3% 72.47 US$478,809
2014-03-11 2014-03-10 S Sale Gergel Ivan P.

EVP, R&D and CSO

Officer
22,126 -44.5%
72.47
US$1,603,471 		22,126 -44.5% 72.47 US$1,603,471
2014-03-11 2014-03-10 S Sale Gergel Ivan P.

EVP, R&D and CSO

Officer
31,162 -53.0%
72.47
US$2,258,310 		31,162 -53.0% 72.47 US$2,258,310
2014-03-11 2014-03-10 S Sale Gergel Ivan P.

EVP, R&D and CSO

Officer
15,742 -36.3%
72.47
US$1,140,823 		15,742 -36.3% 72.47 US$1,140,823
2014-03-11 2014-03-10 S Sale Hutson Nancy J Non-Executive Director
5,000 -19.6%
72.12
US$360,600 		5,000 -19.6% 72.12 US$360,600
2014-03-11 2014-03-10 B Purchase HIGGINS ARTHUR J Non-Executive Director
5,000 +inf%
73.00
US$365,000 		5,000 +inf% 73.00 US$365,000
Explore more

More insider trading research around Endo International PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America